Striverdi Respimat(olodaterol)

COPD — long-term maintenance treatment in adults. Not for sudden symptoms or asthma.

1 DTP program

From $35/mo

1 platform

FDA-Approved Indications

Long-term maintenance of airflow obstruction in COPD

Available direct-to-patient (DTP) programs

Sorted by price, lowest first. Always verify eligibility and pricing directly with the manufacturer.

Lowest price option

via Boehringer Ingelheim Direct · Boehringer Ingelheim

$35/mo

$35/30-day fill. Insurance cannot be billed at any time. Free USPS shipping (7–10 business days). No expiry stated.

Eligibility

US patient. Valid Rx required. No insurance claim permitted. HSA/FSA accepted. Account creation required at BoehringerDirect.

May purchase at cash price. Cannot seek reimbursement or count toward deductible.

Last verified: Mar 2026

Not sure which Striverdi Respimat program fits your situation?